Jan 19, 2022
A new study conducted by researchers at the Brain Tumor Research Center at the University of Plymouth has found that the drugs used to treat HIV and AIDS may be effective in the treatment of low-grade brain tumors. The study’s researchers believe that ARVs could be prescribed for patients who have been diagnosed with acoustic neuroma and meningioma brain tumors, which often grow back after radiotherapy and surgery.
Meningioma is a common primary tumor that may become cancerous as time goes by. This tumor develops from cells found in the meninges, which protect the spinal cord and the brain. On the other hand, an acoustic neuroma is a noncancerous…
NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
On the 30th anniversary of the franchise, Pokémon cards are skyrocketing in value — to the point that collecting them can be a viable livelihood.
EU minister Hamish Falconer insists Britain would have some influence on policy as part of a new deal.
It’s illegal in the United States to transport game fowl for fighting. But investigators say breeders are sending birds to the Philippines, where cockfighting is legal and lucrative.
A planned American-led artificial intelligence hub in the Philippines has sparked fierce opposition over concerns about displacement, resources and threats to national sovereignty.
They will soon be free to all Apple TV users and will appear on more than one billion devices that have the app, including Rokus and smart TVs.
Some parents are so desperate for their children to find a job that they've offered to pay their wages, one hairdresser has told the BBC.
Prominent figures in Silicon Valley want to see Jensen Huang reinstalled as Nvidia’s boss. Some in the Trump administration don’t want him to return.
The announcement came after a New York Times investigation about the restrictive contracts of the group NewJeans, signed when its members were 14 to 17.
A Chinese businessman arrived in Panama with money and power. Then he sold a port when his luck turned. Now China wants him sent back.
Phillips was always an underdog in the auction world, but it had ambition to compete with Christie’s and Sotheby’s. Then the economics changed.
The founder of the collapsed FTX crypto exchange, who is serving prison time for fraud, would have made a windfall from a $500 million investment in Anthropic.
Insurance companies are investing billions of their customers’ money into A.I. deals as analysts warn of mounting risks.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.